Is ProKidney Corp Stock a Good Investment?
ProKidney Corp Investment Advice | PROK |
- Examine ProKidney Corp's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research ProKidney Corp's leadership team and their track record. Good management can help ProKidney Corp navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact ProKidney Corp's business and its evolving consumer preferences.
- Compare ProKidney Corp's performance and market position to its competitors. Analyze how ProKidney Corp is positioned in terms of product offerings, innovation, and market share.
- Check if ProKidney Corp pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about ProKidney Corp's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in ProKidney Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if ProKidney Corp is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine ProKidney Corp Stock
Researching ProKidney Corp's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 27.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.62. ProKidney Corp had not issued any dividends in recent years. The entity had 1:1 split on the 12th of July 2022.
To determine if ProKidney Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ProKidney Corp's research are outlined below:
| ProKidney Corp generated a negative expected return over the last 90 days | |
| ProKidney Corp has some characteristics of a very speculative penny stock | |
| ProKidney Corp has high historical volatility and very poor performance | |
| ProKidney Corp has high likelihood to experience some financial distress in the next 2 years | |
| ProKidney Corp currently holds 2.47 M in liabilities with Debt to Equity (D/E) ratio of 5.66, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ProKidney Corp has a current ratio of 0.73, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ProKidney Corp's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 76 K. Net Loss for the year was (163.34 M) with profit before overhead, payroll, taxes, and interest of 76 K. | |
| ProKidney Corp currently holds about 21.88 M in cash with (126.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| ProKidney Corp has a frail financial position based on the latest SEC disclosures | |
| Roughly 27.0% of ProKidney Corp outstanding shares are owned by corporate insiders |
ProKidney Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ProKidney Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ProKidney Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
ProKidney Corp's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.72 B.Basic technical analysis of ProKidney Stock
As of the 22nd of March, ProKidney Corp holds the Variance of 19.4, risk adjusted performance of (0.16), and Coefficient Of Variation of (523.49). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ProKidney Corp, as well as the relationship between them.ProKidney Corp's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ProKidney Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on ProKidney Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ProKidney Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Understand ProKidney Corp's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing ProKidney Corp's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.16) | |||
| Market Risk Adjusted Performance | (0.47) | |||
| Mean Deviation | 3.58 | |||
| Coefficient Of Variation | (523.49) | |||
| Standard Deviation | 4.4 | |||
| Variance | 19.4 | |||
| Information Ratio | (0.18) | |||
| Jensen Alpha | (0.73) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (0.48) | |||
| Maximum Drawdown | 18.79 | |||
| Value At Risk | (6.73) | |||
| Potential Upside | 6.12 | |||
| Skewness | (0.17) | |||
| Kurtosis | (0.36) |
| Risk Adjusted Performance | (0.16) | |||
| Market Risk Adjusted Performance | (0.47) | |||
| Mean Deviation | 3.58 | |||
| Coefficient Of Variation | (523.49) | |||
| Standard Deviation | 4.4 | |||
| Variance | 19.4 | |||
| Information Ratio | (0.18) | |||
| Jensen Alpha | (0.73) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (0.48) | |||
| Maximum Drawdown | 18.79 | |||
| Value At Risk | (6.73) | |||
| Potential Upside | 6.12 | |||
| Skewness | (0.17) | |||
| Kurtosis | (0.36) |
Consider ProKidney Corp's intraday indicators
ProKidney Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ProKidney Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
ProKidney Corp time-series forecasting models is one of many ProKidney Corp's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ProKidney Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
ProKidney Stock media impact
Far too much social signal, news, headlines, and media speculation about ProKidney Corp that are available to investors today. That information is available publicly through ProKidney media outlets and privately through word of mouth or via ProKidney internal channels. However, regardless of the origin, that massive amount of ProKidney data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ProKidney Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ProKidney Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ProKidney Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ProKidney Corp alpha.
ProKidney Corp Corporate Management
| Ulrich Ernst | EVP Technology | Profile | |
| Joseph MD | VP Devel | Profile | |
| Ashley Johns | VP Operations | Profile | |
| Carla Poulson | Chief Officer | Profile | |
| Lucio Tozzi | Senior Operations | Profile | |
| James CPA | Chief Officer | Profile | |
| Richard Williams | Senior Technology | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between ProKidney Corp's value and its price, as these two are different measures arrived at by various means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.